Study | Reason for exclusion |
Baum 1963 | Quasi-randomised, alternate allocation of patients to groups |
Bayreuther 1994 | Crossover design. |
Can Gurkan 2008 | Planned as a randomised study, but not carried out as planned (patients on each day placed in same group) |
Cartwright 1951 | Crossover design. |
Conklin 1958 | Not randomised, patients “arbitrarily allocated” to groups. |
De Aloysio 1992 | Crossover design. |
Diggory 1962 | Quasi-randomised “each patient in sequence was allocated”; control group reallocated if not improving |
Dundee 1988 | Not an RCT; women allocated to groups by day of the week; non-responders replaced in treatment group |
Evans 1993 | Crossover design. |
Ferruti 1982 | This is a study of hypocorticalism in pregnancy. |
Fitzgerald 1955 | Not an RCT; alternate allocation of patients. |
Heazell 2006 | Severe symptoms, in-patient; hyperemesis gravidarum implied (severe symptoms plus ketonuria) |
Higgins 2009 | Hyperemesis gravidarum (day care versus in-patient management; trial registry record only, no data) |
Hyde 1989 | Crossover design. |
Kadan 2009 | Hyperemesis gravidarum as specified condition of participants (RCT, with crossover if first drug allocated not effective: thiamine 100mg IV or promethazine 25mg IV; started February 2009, trial registry record only, ongoing at May 2010) |
King 1955 | Type of crossover design. |
Koren 2006 | Pre-emptive treatment; not treating symptoms. |
Lask 1953 | Not an RCT. |
Luz 1987 | No data available; this is a communication of a planned trial - a search identified no further publications from this study |
Steele 2001 | Quasi-experimental design posttest-only and post-test repeated measure |
Wheatley 1977 | Crossover design. |
Winters 1961 | Quasi randomised trial - “test material and placebo were strictly alternated” |
IV: intravenous
RCT: randomised controlled trial